搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Notechis scutatus scutatus Venom nerve growth factor 2 CSB-YP659070NHT
CSB-EP659070NHT
CSB-BP659070NHT
CSB-MP659070NHT
CSB-EP659070NHT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Triticum aestivum Gibberellin 3-beta-dioxygenase 2-3 (GA3ox2-3) CSB-YP659071TQN
CSB-EP659071TQN
CSB-BP659071TQN
CSB-MP659071TQN
CSB-EP659071TQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bat coronavirus Rp3/2004 Protein 9b (9b) CSB-YP659072BFE
CSB-EP659072BFE
CSB-BP659072BFE
CSB-MP659072BFE
CSB-EP659072BFE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bat coronavirus Rp3/2004 Protein 3 (3), partial CSB-YP659073BFE1
CSB-EP659073BFE1
CSB-BP659073BFE1
CSB-MP659073BFE1
CSB-EP659073BFE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Chaperone protein DnaK (dnaK), partial CSB-YP659074PTP
CSB-EP659074PTP
CSB-BP659074PTP
CSB-MP659074PTP
CSB-EP659074PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis UPF0745 protein PSHAb0508 (PSHAb0508) CSB-YP659075PTP
CSB-EP659075PTP
CSB-BP659075PTP
CSB-MP659075PTP
CSB-EP659075PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Purine nucleoside phosphorylase DeoD-type (deoD) CSB-YP659076PTP
CSB-EP659076PTP
CSB-BP659076PTP
CSB-MP659076PTP
CSB-EP659076PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Nucleoside diphosphate kinase (ndk) CSB-YP659077PTP
CSB-EP659077PTP
CSB-BP659077PTP
CSB-MP659077PTP
CSB-EP659077PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Glycine--tRNA ligase alpha subunit (glyQ) CSB-YP659078PTP
CSB-EP659078PTP
CSB-BP659078PTP
CSB-MP659078PTP
CSB-EP659078PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP659079PTP
CSB-EP659079PTP
CSB-BP659079PTP
CSB-MP659079PTP
CSB-EP659079PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Thymidylate synthase (thyA) CSB-YP659080PTP
CSB-EP659080PTP
CSB-BP659080PTP
CSB-MP659080PTP
CSB-EP659080PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Cell division protein FtsB (ftsB), partial CSB-YP659081PTP
CSB-EP659081PTP
CSB-BP659081PTP
CSB-MP659081PTP
CSB-EP659081PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP659082PTP
CSB-EP659082PTP
CSB-BP659082PTP
CSB-MP659082PTP
CSB-EP659082PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (ispH) CSB-YP659083PTP
CSB-EP659083PTP
CSB-BP659083PTP
CSB-MP659083PTP
CSB-EP659083PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis 30S ribosomal protein S16 (rpsP) CSB-YP659084PTP
CSB-EP659084PTP
CSB-BP659084PTP
CSB-MP659084PTP
CSB-EP659084PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Gamma-glutamyl phosphate reductase (proA) CSB-YP659085PTP
CSB-EP659085PTP
CSB-BP659085PTP
CSB-MP659085PTP
CSB-EP659085PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis 50S ribosomal protein L2 (rplB) CSB-YP659086PTP
CSB-EP659086PTP
CSB-BP659086PTP
CSB-MP659086PTP
CSB-EP659086PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis tRNA pseudouridine synthase A (truA) CSB-YP659087PTP
CSB-EP659087PTP
CSB-BP659087PTP
CSB-MP659087PTP
CSB-EP659087PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis NH (3)-dependent NAD (+) synthetase (nadE) CSB-YP659088PTP
CSB-EP659088PTP
CSB-BP659088PTP
CSB-MP659088PTP
CSB-EP659088PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis UPF0758 protein PSHAa2643 (PSHAa2643) CSB-YP659089PTP
CSB-EP659089PTP
CSB-BP659089PTP
CSB-MP659089PTP
CSB-EP659089PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>